Connect with us

Health

AstraZeneca warns German reforms could push pharma launches and investment out of Europe

SHARE:

Published

2 weeks ago

on

We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. You can unsubscribe at any time.

AstraZeneca CEO warns that pharma may avoid launching new medicines in Europe’s largest market.

In an interview in German business paper Handelsblatt, AstraZeneca CEO Pascal Soriot reacted to proposed health reforms saying that AZ would by unable to launch some products in Germany: "It's going to be very hard for us, we're going to be attacked, but in the end, we will have no ⁠choice, also because of the pressure in the US.”

In March, a commission of experts presented a list of 66 cost-saving proposals to curb spiralling German healthcare costs, potentially offering policymakers a menu of measures that could reshape the country's statutory health insurance system.

Last week, the Health Minister Nina Warken...

Share this article:

Share this:
Related Topics:
Guest Contributor - Opinion

Opinions expressed are purely those of the author and not endorsed by EU Reporter.

EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.
Advertisement

Trending